Oral Tofacitinib for the Management of Moderate to Severe Alopecia Areata in Children and Adolescents: A Retrospective Study of 36 Patients

This retrospective study evaluated the effectiveness of oral Tofacitinib in managing moderate to severe alopecia areata (AA) in 36 children and adolescents. The findings indicate that Tofacitinib is effective in promoting rapid hair regrowth in responders. However, the study highlights the need for further investigation into the durability of the treatment's benefits and the necessity for long-term maintenance therapy.